Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cervical Cancer Brachytherapy Amid the Pandemic: A Single Institutional Case Series



Siavashpour Z1 ; Jafari F2, 4 ; Aghili M2, 4 ; Jafari A1 ; Jaberi R2, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Radiotherapy Oncology Department, Shohada Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Department of Radiation Oncology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Physics, University of Surrey, Guildford, United Kingdom
  4. 4. Radiation Oncology Research Center, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

Source: Onkologia i Radioterapia Published:2021

Abstract

Dose escalation to target volume during High Dose Rate brachytherapy was effectively employed to treat locally advanced cervical cancer patients who experienced prolongation of Overall Treatment Time (OTT) due to the COVID-19 pandemic. It was tried to achieve acceptable oncological outcomes while respecting the dose constraints of Organs at Risk (OARs). Key Clinical Message: It was a severe challenge to obey the optimum treatment schedule of LACC cases during the coronavirus crisis. Increased risk of recurrence and mortality due to increased overall treatment time in cervical cancer patients proposes prioritizing. © 2021, Medical Project Poland. All rights reserved.
Related Docs
1. Optimum Organ Volume Ranges for Organs at Risk Dose in Cervical Cancer Intracavitary Brachytherapy, Journal of Contemporary Brachytherapy (2016)